Chord Therapeutics

Chord Therapeutics

Developing drugs for patients with rare, life-threatening, and severely disabling diseases.

Launch date
Employees
Market cap
-
Enterprise valuation
AUD99—148m (Dealroom.co estimates Oct 2020.)
Company register number CHE-284.001.182
Geneva Canton of Geneva (HQ)
Authorizing premium user...